Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Associations between molecular classification and response to intra-uterine levonorgestrel device therapy in patients with medically managed endometrial cancer and endometrial intra-epithelial neoplasia: a multi-center Endometrial Cancer Molecularly Targeted Therapy (ECMT2) Consortium study.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

Rethinking ovarian cancer III: the past decade and future directions.

Nature reviews. Cancer·2026
Same author

Correction: GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress.

Molecular cancer research : MCR·2026
Same author

AXL inhibition improves the therapeutic efficacy of trastuzumab in high-risk endometrial cancer.

Gynecologic oncology·2025
Same author

In vivo genome-wide CRISPR screens in human T cells to enhance T cell therapy for solid tumors.

bioRxiv : the preprint server for biology·2025
Same author

Targeting RAD52 overcomes PARP inhibitor resistance in preclinical <i>Brca2</i>-deficient ovarian cancer model.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Oct 9, 2025

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity
09:00

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity

Published on: December 31, 2015

26.8K

Culturing Primary Human Mesothelial Cells.

Mary Mullen1, Hollie Noia1, Katherine Fuh2

  • 1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.

Methods in Molecular Biology (Clifton, N.J.)
|December 17, 2021
PubMed
Summary
This summary is machine-generated.

Ovarian cancer metastasis requires tumor cells to overcome mesothelial cells. This study details methods for obtaining and culturing human primary mesothelial cells (HPMCs) for ovarian cancer research.

Keywords:
CultureHuman omentumMesothelial cellsOvarian cancerPrimary mesothelial cells

More Related Videos

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.0K
A Proximal Culture Method to Study Paracrine Signaling Between Cells
08:17

A Proximal Culture Method to Study Paracrine Signaling Between Cells

Published on: August 28, 2018

9.6K

Related Experiment Videos

Last Updated: Oct 9, 2025

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity
09:00

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity

Published on: December 31, 2015

26.8K
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.0K
A Proximal Culture Method to Study Paracrine Signaling Between Cells
08:17

A Proximal Culture Method to Study Paracrine Signaling Between Cells

Published on: August 28, 2018

9.6K

Area of Science:

  • Oncology
  • Cell Biology
  • Histology

Background:

  • Mesothelial cells form a critical barrier in serosal cavities.
  • Ovarian cancer metastasis involves overcoming this mesothelial barrier.
  • Understanding mesothelial cell interactions is key to studying cancer spread.

Purpose of the Study:

  • To establish reliable methods for isolating human primary mesothelial cells (HPMCs).
  • To enable in vitro studies of ovarian cancer cell interactions with mesothelial cells.
  • To facilitate research into the mechanisms of ovarian cancer metastasis.

Main Methods:

  • Isolation of HPMCs from human omentum tissue.
  • Establishment of in vitro cell culture protocols for HPMCs.
  • Characterization of isolated HPMCs (details not provided in abstract).

Main Results:

  • Successful isolation of viable HPMCs from human omentum.
  • Established protocols for culturing HPMCs in vitro.
  • HPMCs are now available for experimental use.

Conclusions:

  • Human primary mesothelial cells (HPMCs) can be effectively obtained and cultured.
  • These methods provide a crucial resource for studying ovarian cancer metastasis.
  • Further research using HPMCs will elucidate cancer cell-mesothelial interactions.